
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
1 Department of Gastroenterology, Graduate School of Medicine, and 2 Interfaculty Initiative in Information Studies, Graduate School of Interdisciplinary Information Studies, Department of Biostatistics/Epidemiology and Preventive Health Sciences, School of Health Sciences and Nursing, University of Tokyo, Tokyo, Japan
Purpose: Genetic polymorphisms of UDP-glucuronosyltransferase 1A7 (UGT1A7), which detoxifies endogenous and environmental carcinogens, have been reported to be associated with hepatocellular carcinoma (HCC) in German populations. On the other hand, we reported that interleukin-1ß (IL-1ß) gene polymorphisms were associated with hepatitis C virus (HCV)-related HCC. In this study, we evaluated the association of both genes with the risk of HCC in Japanese HCV-infected patients.
Experimental Design: Genetic polymorphisms of UGT1A7 and IL-1ß were investigated in 280 Japanese patients (122 with HCC and 158 without HCC) with chronic HCV infections, by use of standard PCR-based genotyping techniques.
Results: We designated the UGT1A7*1 allele (a haplotype conferring higher activity) as H and the *2, *3, and *4 alleles (haplotypes conferring lower activity) as L. The proportions of UGT1A7 L/L and H/L alleles (genotypes) in patients with HCC (25% and 45%, respectively) were higher than those in patients without HCC (15% and 39%, respectively) with odds ratios of 2.73 (95% confidence interval, 1.405.35) and 1.80 (95% confidence interval, 1.053.09), respectively, compared with the UGT1A7 H/H alleles. Multivariate analyses revealed that UGT1A7 L/L and IL-1ß/31T/T511C/C genotypes, the presence of cirrhosis, age >60 years, male sex, and
-fetoprotein >20 µg/ml were associated with the presence of HCC (odds ratios, 2.33, 2.67, 4.20, 3.12, 3.09, and 2.90, respectively).
Conclusion: The UGT1A7 polymorphisms together with IL-1ß were associated with the presence of HCC in Japanese HCV-infected patients.
This article has been cited by other articles:
![]() |
A. Budhu and X. W. Wang The role of cytokines in hepatocellular carcinoma J. Leukoc. Biol., December 1, 2006; 80(6): 1197 - 1213. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dharel, N. Kato, R. Muroyama, M. Moriyama, R.-X. Shao, T. Kawabe, and M. Omata MDM2 Promoter SNP309 Is Associated with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C. Clin. Cancer Res., August 15, 2006; 12(16): 4867 - 4871. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Han, H.-S. Lim, E. S. Shin, Y.-K. Yoo, Y. H. Park, J.-E. Lee, I.-J. Jang, D. Ho Lee, and J. Soo Lee Comprehensive Analysis of UGT1A Polymorphisms Predictive for Pharmacokinetics and Treatment Outcome in Patients With Non-Small-Cell Lung Cancer Treated With Irinotecan and Cisplatin J. Clin. Oncol., May 20, 2006; 24(15): 2237 - 2244. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. O. Lankisch, A. Vogel, S. Eilermann, A. Fiebeler, B. Krone, A. Barut, M. P. Manns, and C. P. Strassburg Identification and Characterization of a Functional TATA Box Polymorphism of the UDP Glucuronosyltransferase 1A7 Gene Mol. Pharmacol., May 1, 2005; 67(5): 1732 - 1739. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Liu, F. Innocenti, M. J. Ratain, N. Kato, Y. Wang, and M. Omata Linkage Disequilibrium across the UGT1A Locus Should Not Be Ignored in Association Studies of Cancer Susceptibility Clin. Cancer Res., February 1, 2005; 11(3): 1348 - 1349. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |